|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
1734719478 |
003 |
DE-627 |
005 |
20230427033732.0 |
007 |
tu |
008 |
200923s2020 gw ||||| 00| ||ger c |
015 |
|
|
|a 20,N39
|2 dnb
|
015 |
|
|
|a 20,A44
|2 dnb
|
016 |
7 |
|
|a 1217804978
|2 DE-101
|
020 |
|
|
|a 9783945267059
|c : (Broschur : EUR 34.90 (DE), EUR 35.90 (AT))
|9 978-3-945267-05-9
|
020 |
|
|
|a 3945267056
|9 3-945267-05-6
|
024 |
3 |
|
|a 9783945267059
|
035 |
|
|
|a (DE-627)1734719478
|
035 |
|
|
|a (DE-599)DNB1217804978
|
035 |
|
|
|a (OCoLC)1220894290
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
041 |
|
|
|a ger
|
044 |
|
|
|c XA-DE-BY
|
060 |
|
0 |
|a WC 195
|
082 |
0 |
|
|a 616.90461
|q DE-101
|
082 |
0 |
4 |
|a 610
|q DE-101
|
084 |
|
|
|a XI 3600
|q DE-14/sred
|2 rvk
|0 (DE-625)rvk/152998:
|
084 |
|
|
|a 44.75
|2 bkl
|
084 |
|
|
|a 44.38
|2 bkl
|
100 |
1 |
|
|a Abele-Horn, Marianne
|d 1947-
|e verfasserin
|0 (DE-588)109467108
|0 (DE-627)558726402
|0 (DE-576)173281028
|4 aut
|
245 |
1 |
0 |
|a Antimikrobielle Therapie
|b Entscheidungshilfen zur Behandlung und Prophylaxe von Infektionskrankheiten
|c Marianne Abele-Horn ; unter Mitarbeit von Helmut Fickenscher, Werner Heinz, Stephan Horn, Elvira Richter, Wiltrud Pobst und Andreas Wieser
|
250 |
|
|
|a 4. überarbeitete und erweiterte Auflage
|
264 |
|
1 |
|a Ebelsbach
|b Aktiv Druck & Verlag GmbH
|c [2020]
|
300 |
|
|
|a 680 Seiten
|b Diagramme
|c 17 cm, 488 g
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
650 |
|
2 |
|a Cross Infection
|a Prevention and control
|2 DE-289
|
650 |
|
2 |
|a Anti-bacterial agents
|2 DE-289
|
650 |
|
2 |
|a Cross Infection
|x prevention and control
|
650 |
|
2 |
|a Anti-Bacterial Agents
|
689 |
0 |
0 |
|D s
|0 (DE-588)4026879-2
|0 (DE-627)104288914
|0 (DE-576)208968350
|a Infektionskrankheit
|2 gnd
|
689 |
0 |
1 |
|D s
|0 (DE-588)4076308-0
|0 (DE-627)104364106
|0 (DE-576)209201428
|a Prävention
|2 gnd
|
689 |
0 |
2 |
|D s
|0 (DE-588)4142688-5
|0 (DE-627)105611298
|0 (DE-576)209720662
|a Antimikrobieller Wirkstoff
|2 gnd
|
689 |
0 |
|
|5 DE-101
|
689 |
1 |
0 |
|D s
|0 (DE-588)4026879-2
|0 (DE-627)104288914
|0 (DE-576)208968350
|a Infektionskrankheit
|2 gnd
|
689 |
1 |
1 |
|D s
|0 (DE-588)4059798-2
|0 (DE-627)106142216
|0 (DE-576)209132310
|a Therapie
|2 gnd
|
689 |
1 |
2 |
|D s
|0 (DE-588)4142688-5
|0 (DE-627)105611298
|0 (DE-576)209720662
|a Antimikrobieller Wirkstoff
|2 gnd
|
689 |
1 |
|
|5 DE-101
|
700 |
1 |
|
|a Fickenscher, Helmut
|d 1962-
|e verfasserin
|0 (DE-588)141682663
|0 (DE-627)630420939
|0 (DE-576)325345317
|4 aut
|
710 |
2 |
|
|a MEPS - Medical Event & Publisher Services
|g Nürnberg
|e Verlag
|0 (DE-588)10202962-3
|0 (DE-627)566359987
|0 (DE-576)280639058
|4 pbl
|
856 |
4 |
2 |
|u https://d-nb.info/1217804978/04
|m B:DE-101
|q application/pdf
|v 2020-10-28
|x Verlag
|3 Inhaltsverzeichnis
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a ISIL_DE-18
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_22_i06404
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a ISIL_DE-8
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a ISIL_DE-9
|
912 |
|
|
|a GBV_ILN_101
|
912 |
|
|
|a ISIL_DE-Ma14
|
912 |
|
|
|a GBV_ILN_348
|
912 |
|
|
|a ISIL_DE-Nbg4
|
912 |
|
|
|a GBV_ILN_711
|
912 |
|
|
|a ISIL_DE-Bd7
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a ISIL_DE-14
|
912 |
|
|
|a GBV_ILN_2018
|
912 |
|
|
|a ISIL_DE-31
|
912 |
|
|
|a GBV_ILN_2021
|
912 |
|
|
|a ISIL_DE-289
|
912 |
|
|
|a GBV_ILN_2141
|
912 |
|
|
|a ISIL_DE-16-300
|
936 |
r |
v |
|a XI 3600
|b Hand- und Lehrbücher, einführende Werke
|k Medizin
|k Pharmakologie und Toxikologie
|k Spezielle Pharmakologie und Toxikologie
|k Chemotherapie
|k Antibiotika
|k Hand- und Lehrbücher, einführende Werke
|0 (DE-627)1271601249
|0 (DE-625)rvk/152998:
|0 (DE-576)201601249
|
936 |
b |
k |
|a 44.75
|j Infektionskrankheiten
|j parasitäre Krankheiten
|x Medizin
|0 (DE-627)106415948
|
936 |
b |
k |
|a 44.38
|j Pharmakologie
|0 (DE-627)106409743
|
951 |
|
|
|a BO
|
953 |
|
|
|2 045F
|a 616.90461
|
980 |
|
|
|2 22
|1 02
|x 0018
|b 4294493968
|c 00
|f 18/64
|d WC 195 Med A 2020/135
|e u
|j --%%--
|c 03
|f --%%--
|d Med A 2020/135
|e --%%--
|j --%%--
|y zi06404
|z 22-03-23
|
980 |
|
|
|2 24
|1 01
|x 8/202
|b 3796258018
|c 00
|f 28 mdk 116
|d MT 7624
|e u
|j --%%--
|h ma
|y zz1
|z 10-11-20
|
980 |
|
|
|2 69
|1 01
|x 0009
|b 4311556349
|c 00
|f PA 316
|d 660/XI 3600 A141
|e g
|j --%%--
|y z
|z 21-06-23
|
980 |
|
|
|2 101
|1 01
|x 3101
|b 3810563293
|c 00
|f 0521.03
|d ZB -0521-295 : 4
|e u
|j --%%--
|h ACQ
|y z
|z 22-01-21
|
980 |
|
|
|2 348
|1 01
|x 4348
|b 4129896601
|c 00
|f MB
|d 0521 03
|e c
|j --%%--
|y zm
|z 06-05-22
|
980 |
|
|
|2 711
|1 01
|x 3806
|b 3816533221
|c 00
|f --%%--
|d Apotheke
|e g
|j --%%--
|y n
|z 03-12-20
|
980 |
|
|
|2 2006
|1 01
|x DE-14
|b 3881753575
|c 00
|f --%%--
|d --%%--
|e --%%--
|j --%%--
|y l01
|z 04-03-21
|
980 |
|
|
|2 2018
|1 01
|x DE-31
|b 3956512111
|c 00
|f --%%--
|d --%%--
|e --%%--
|j l
|y l01
|z 21-07-21
|
980 |
|
|
|2 2021
|1 01
|x DE-289
|b 3881725458
|c 00
|f --%%--
|d UKU QV 350/2020 A
|e --%%--
|j n
|y l01
|z 04-03-21
|
980 |
|
|
|2 2141
|1 01
|x DE-16-300
|b 3826581814
|c 00
|f 275
|d U 4
|e s
|j --%%--
|y l01
|z 17-12-20
|
980 |
|
|
|2 2141
|1 02
|x DE-16-300
|b 3834847127
|c 00
|f 275
|d U 4
|e s
|j --%%--
|y l02
|z 13-01-21
|
980 |
|
|
|2 2141
|1 03
|x DE-16-300
|b 3834847798
|c 00
|f 275
|d U 4
|e s
|j --%%--
|y l03
|z 13-01-21
|
980 |
|
|
|2 2141
|1 04
|x DE-16-300
|b 3834848565
|c 00
|f 275
|d U 4
|e s
|j --%%--
|y l04
|z 13-01-21
|
980 |
|
|
|2 2141
|1 05
|x DE-16-300
|b 3834849065
|c 00
|f 275
|d U 4
|e s
|j --%%--
|y l05
|z 13-01-21
|
980 |
|
|
|2 2141
|1 06
|x DE-16-300
|b 3834849316
|c 00
|f 275
|d U 4
|e s
|j --%%--
|y l06
|z 13-01-21
|
980 |
|
|
|2 2141
|1 07
|x DE-16-300
|b 3834849936
|c 00
|f 275
|d U 4
|e s
|j --%%--
|y l07
|z 13-01-21
|
980 |
|
|
|2 2141
|1 08
|x DE-16-300
|b 3834850381
|c 00
|f 275
|d U 4
|e s
|j --%%--
|y l08
|z 13-01-21
|
982 |
|
|
|2 348
|1 00
|x DE-Nbg4
|8 00
|a Infektionen, Therapie
|
982 |
|
|
|2 348
|1 00
|x DE-Nbg4
|8 00
|a Infektionen, Prophylaxe
|
982 |
|
|
|2 348
|1 00
|x DE-Nbg4
|8 00
|a Antibiotika
|
982 |
|
|
|2 711
|1 01
|x 3806
|8 00
|a Organ- und Erregerbezogene Therapie, Antibiogramm
|
982 |
|
|
|2 711
|1 01
|x 3806
|8 01
|a Postexpositionsprophylaxe, Penicillinallergie
|
983 |
|
|
|2 24
|1 01
|x 8/202
|8 50
|0 (DE-627)1005016194
|a mdk 116.100
|b Antibiotika
|
983 |
|
|
|2 69
|1 00
|x DE-9
|8 00
|a XI 3600
|
983 |
|
|
|2 101
|1 00
|x DE-Ma14
|8 00
|a 0521.03
|
983 |
|
|
|2 101
|1 00
|x DE-Ma14
|8 01
|a 0602.01
|
983 |
|
|
|2 348
|1 00
|x DE-Nbg4
|8 00
|a 0521 03
|
983 |
|
|
|2 348
|1 00
|x DE-Nbg4
|8 00
|a 0602 09
|
983 |
|
|
|2 711
|1 01
|x 3806
|8 00
|a XI 2900 Spezielle Pharmakologie
|
984 |
|
|
|2 22
|1 02
|x 0018
|a 962467613
|
984 |
|
|
|2 24
|1 01
|x 8/202
|a 8$0014200228
|
984 |
|
|
|2 69
|1 01
|x 0009
|a 9$12517895
|
984 |
|
|
|2 101
|1 01
|x 3101
|a MA14$1167545
|
984 |
|
|
|2 2141
|1 01
|x DE-16-300
|a 590696860
|
984 |
|
|
|2 2141
|1 02
|x DE-16-300
|a 590696872
|
984 |
|
|
|2 2141
|1 03
|x DE-16-300
|a 590696884
|
984 |
|
|
|2 2141
|1 04
|x DE-16-300
|a 590696896
|
984 |
|
|
|2 2141
|1 05
|x DE-16-300
|a 590696903
|
984 |
|
|
|2 2141
|1 06
|x DE-16-300
|a 590696915
|
984 |
|
|
|2 2141
|1 07
|x DE-16-300
|a 590696927
|
984 |
|
|
|2 2141
|1 08
|x DE-16-300
|a 590696939
|
985 |
|
|
|2 22
|1 02
|x 0018
|a ukev2020.0568
|
985 |
|
|
|2 69
|1 01
|x 0009
|a 2023.2874
|
985 |
|
|
|2 348
|1 01
|x 4348
|a 86/2022
|
985 |
|
|
|2 711
|1 01
|x 3806
|a 20.211 Apotheke/SKB
|
985 |
|
|
|2 2141
|1 01
|x DE-16-300
|a m/2000306
|
985 |
|
|
|2 2141
|1 02
|x DE-16-300
|a m/2000307
|
985 |
|
|
|2 2141
|1 03
|x DE-16-300
|a m/2000308
|
985 |
|
|
|2 2141
|1 04
|x DE-16-300
|a m/2000309
|
985 |
|
|
|2 2141
|1 05
|x DE-16-300
|a m/2000310
|
985 |
|
|
|2 2141
|1 06
|x DE-16-300
|a m/2000311
|
985 |
|
|
|2 2141
|1 07
|x DE-16-300
|a m/2000312
|
985 |
|
|
|2 2141
|1 08
|x DE-16-300
|a m/2000313
|
995 |
|
|
|2 24
|1 01
|x 8/202
|a ma
|
995 |
|
|
|2 101
|1 01
|x 3101
|a ACQ
|